Ullet index:GNI Group Ltd.:2160

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index GNI Group Ltd. Go to web site 2160 Medicals 東証グロース December 1, 2000 2007.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

GNI Group Ltd. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 36,406
plusup
33,794
plusup
20,970
plusup
18,860
plusup
11,000
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 978
plusdown
8,094
plusup
389
plusdown
1,066
plusdown
1,258
plus
Operating Cash Flow(OFC)Help -3,164
plusdown
6,549
plusup
393
plusdown
552
plusdown
1,378
plus
Free Cash Flow(FCF)Help -13,526
plusdown
-293
plusup
-3,723
plusdown
292
plusdown
1,948
plus
OFC - Net IncomeHelp 76
plusdown
86
plusup
85
plusdown
87
plusup
84
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp -132.79%
plusdown
146.93%
plusup
2.79%
plusdown
7.85%
plusdown
133.39%
plus
Current Assets / Amount of SalesHelp -10.09%
plusdown
17.14%
plusdown
80.80%
plusup
55.41%
plusup
10.57%
plus
Free Cash Revenue RatioHelp -57.28%
plusdown
-1.13%
plusup
-21.37%
plusdown
2.30%
plusdown
19.93%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

GNI Group Ltd.

Company where related level is highHelp

ONO PHARMACEUTICAL CO.,LTD.
TORII PHARMACEUTICAL CO.,LTD.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
Fuso Pharmaceutical Industries, Ltd.
Nippon Shinyaku Co.,Ltd.
Tsubota Laboratory Incorporated
Nxera Pharma Co., Ltd.
FunPep Company Limited
Kringle Pharma,Inc.
Oncolys BioPharma Inc.